Amway (Malaysia) Holdings Berhad operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Amway (Malaysia) Holdings Berhad with three other
drug stores in Asia:
Kingworld Medicines Group Limited
sales of 1.05 billion Chinese Renmimbi [US$154.09 million]
of which 90%
was Distribution sales of pharmaceutical and),
Hua Xia Healthcare Holdings Limited
of Hong Kong
(1.57 billion Hong Kong Dollars [US$201.88 million]
of which 84%
was Pharmaceutical Wholesale), and
China Pioneer Pharma Holdings Ltd
based in China
(1.79 billion Chinese Renmimbi [US$261.85 million]
of which 57%
was Products sold via the provision of co-pr).
Amway (Malaysia) Holdings Berhad reported sales of 1.09 billion Malaysian Ringgits (US$253.62 million)
December of 2016.
increase of 6.6%
versus 2015, when the company's sales were 1.02 billion Malaysian Ringgits.
Sales at Amway (Malaysia) Holdings Berhad have increased during each of the previous five years
(and since 2011, sales have increased a total of 48%).